Cargando…
Oral Contraceptive Steroids Promote Papillary Thyroid Cancer Metastasis by Targeting Angiogenesis and Epithelial-Mesenchymal Transition
Thyroid cancer is the most prevalent type of endocrine malignancy with the highest incidence rate among women under 45 years old. Ethinylestradiol (EE) and levonorgestrel (LNG) are two steroid components of low-dose oral contraceptives used all over the world. In this study, we aimed to examine the...
Autores principales: | Dehghan, Mohammad Hossein, Ashrafi, Mohammad Reza, Hedayati, Mehdi, Shivaee, Setareh, Rajabi, Sadegh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Babol University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800459/ https://www.ncbi.nlm.nih.gov/pubmed/35178360 http://dx.doi.org/10.22088/IJMCM.BUMS.10.3.218 |
Ejemplares similares
-
Papillary Thyroid Cancer-Promoting Activities of Combined Oral Contraceptive Components
por: Hedayati, Mehdi, et al.
Publicado: (2020) -
NOL4 is Downregulated and Hyper-Methylated in Papillary Thyroid Carcinoma Suggesting Its Role as a Tumor Suppressor Gene
por: Sheikholeslami, Sara, et al.
Publicado: (2020) -
The Epigenetic Modification of SLC5A8 in Papillary Thyroid Carcinoma and its Effects on Clinic-Pathological Features
por: Sheikholeslami, Sara, et al.
Publicado: (2022) -
Validation of Reference Genes for Normalization of Relative qRT-PCR Studies in Papillary Thyroid Carcinoma
por: Razavi, S. Adeleh, et al.
Publicado: (2019) -
Leptin: A Correlated Peptide to Papillary Thyroid Carcinoma?
por: Hedayati, Mehdi, et al.
Publicado: (2011)